Arrowhead Pharmaceuticals, Inc. Stock Performance
as on September 10, 2025 at 1:29 am IST
Day's Low
Day's High
$27.15$27.82
2.13%
Downside
0.29%
Upside
52 Week's Low
52 Week's High
$9.57$29.3465.50%
Downside
5.77%
Upside
Arrowhead Pharmaceuticals, Inc. share price movements today
- Previous Close
- $27.17
- Open
- $27.43
- Volume
- 2.0M
- Day's Low - High
- $27.15 - $27.82
- 52 Week Low - High
- $9.57 - $29.34
Arrowhead Pharmaceuticals, Inc. Historical Returns
- 1 Month Return
- + 77.07 %
- 3 Month Return
- + 75.47 %
- 1 Year Return
- + 33.62 %
- 3 Year Return
- -24.62 %
- 5 Year Return
- -19.55 %
Arrowhead Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Check Arrowhead Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.8B
EPS (TTM)
-0.1825
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.10%
PE Ratio (TTM)
-5.56
Industry PE ratio
-51.37
P/B Ratio
0PEG Ratio
-1.32
EBITDA
-85.4M
Revenue (TTM)
573.0M
Profit Margin
-25.90%
Return On Equity TTM
1614750100.00%
Arrowhead Pharmaceuticals, Inc. Stock Valuation
Track how Arrowhead Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Arrowhead Pharmaceuticals, Inc. in the last 5 years
Lowest (0.00x)
September 9, 2025
Industry (-51.37x)
September 9, 2025
Today (-5.56x)
September 9, 2025
Highest (0.00x)
September 9, 2025
Today’s Price to Earnings Ratio: -5.56x
Arrowhead Pharmaceuticals, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Arrowhead Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.8B | -19.55% | -5.56 | -25.90% | |
| BUY | $59.6B | 267.3% | -505.15 | -12.96% | |
| NA | $39.2B | NA | NA | -3.89% | |
| BUY | $101.3B | 50.26% | 28.09 | 31.86% | |
| BUY | $59.2B | -2.23% | 14.06 | 31.37% |
Stock Returns calculator for Arrowhead Pharmaceuticals, Inc. Stock including INR - Dollar returns
The Arrowhead Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Arrowhead Pharmaceuticals, Inc. investment value today
Current value as on today
₹1,32,460
Returns
₹32,460
(+32.46%)
Returns from Arrowhead Pharmaceuticals, Inc. Stock
₹27,482 (+27.48%)
Dollar Returns*
₹4,978 (+4.98%)
Analyst Recommendation on Arrowhead Pharmaceuticals, Inc. Stock
Based on 20 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 20 analysts, 75% of analysts recommend a 'BUY' rating for Arrowhead Pharmaceuticals, Inc.. Average target price of $46.15
Arrowhead Pharmaceuticals, Inc. Share Price Target
Get share price movements and forecasts by analysts on Arrowhead Pharmaceuticals, Inc..
What analysts predicted
39.89%UPSIDE
Target Price
$46.15
Current Price
$27.74
Analyzed by
20 Analysts
Target
$46.15
Arrowhead Pharmaceuticals, Inc. target price $46.15, a slight upside of 39.89% compared to current price of $27.74. According to 20 analysts rating.
Arrowhead Pharmaceuticals, Inc. Stock's Interest Amongst Investors
Search interest for Arrowhead Pharmaceuticals, Inc. Stock has increased by 103% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:103% versus previous 30 day period
Arrowhead Pharmaceuticals, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Arrowhead Pharmaceuticals, Inc. Annual Profit & Loss
All numbers in Millions USD
Arrowhead Pharmaceuticals, Inc. Quarterly Cash Flow
All numbers in Millions USD
Arrowhead Pharmaceuticals, Inc. Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. News & Key Events
Today's Timeline - 01 August
Fri, 04:00 PM
-Arrowhead's subsidiary Visirna sells rights to plozasiran in Greater China to Sanofi for $130 million upfront.
Insights on Arrowhead Pharmaceuticals, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, ARWR stock has moved up by 65.3%
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 79.8% return, outperforming this stock by 55.1%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 103.8% return, outperforming this stock by 133.4%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 542.70M → 27.76M (in $), with an average decrease of 94.9% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 370.44M → -175.24M (in $), with an average decrease of 147.3% per quarter
About Arrowhead Pharmaceuticals, Inc.
| Organisation | Arrowhead Pharmaceuticals, Inc. |
| Headquarters | 177 East Colorado Boulevard, Pasadena, CA, United States, 91105 |
| Industry | Health Technology |
| CEO | Dr. Christopher R. Anzalone Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Arrowhead Pharmaceuticals, Inc.
Name | Title |
|---|---|
Mr. Daniel J. Apel | Chief Financial Officer |
Dr. Vincent Anzalone CFA | Head of Investor Relations & VP |
Mr. Howard Lovy | Director of Communications |
Dr. Christopher R. Anzalone Ph.D. | Chairman, CEO & President |
Mr. Patrick O'Brien J.D., PharmD | COO, General Counsel & Secretary |
Dr. James C. Hamilton M.D., MBA | Chief Medical Officer and Head of R&D |
Dr. Mark M. Davis Ph.D. | Founder and Founder & Director of Insert Therapeutics Inc & Calando |
Dr. Bruce D. Given M.D. | Chief Medical Scientist |
Dr. Mark Seefeld | Head of Toxicology & VP |
Aaron Tan | Head of Tax |
FAQs
What is Arrowhead Pharmaceuticals, Inc. share price today?
Arrowhead Pharmaceuticals, Inc. share price today is $27.74 as on at the close of the market. Arrowhead Pharmaceuticals, Inc. share today touched a day high of $27.82 and a low of $27.15.
What is the 52 week high and 52 week low for Arrowhead Pharmaceuticals, Inc. share?
Arrowhead Pharmaceuticals, Inc. share touched a 52 week high of $29.34 on and a 52 week low of $9.57 on . Arrowhead Pharmaceuticals, Inc. stock price today i.e. is closed at $27.74,which is 5.45% down from its 52 week high and 189.86% up from its 52 week low.
What is Arrowhead Pharmaceuticals, Inc.'s market capitalisation today?
Arrowhead Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
How to invest in Arrowhead Pharmaceuticals, Inc. Stock (ARWR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Arrowhead Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arrowhead Pharmaceuticals, Inc. Shares that will get you 0.0541 shares as per Arrowhead Pharmaceuticals, Inc. share price of $27.74 per share as on September 10, 2025 at 1:29 am IST.
What is the minimum amount required to buy Arrowhead Pharmaceuticals, Inc. Stock (ARWR) from India?
Indian investors can start investing in Arrowhead Pharmaceuticals, Inc. (ARWR) shares with as little as ₹88.135 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.35 in Arrowhead Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arrowhead Pharmaceuticals, Inc. share’s latest price of $27.74 as on September 10, 2025 at 1:29 am IST, you will get 0.3605 shares of Arrowhead Pharmaceuticals, Inc.. Learn more about
fractional shares .
What are the returns that Arrowhead Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?
Arrowhead Pharmaceuticals, Inc. stock has given -19.55% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?